Eric De La Fortelle

Eric is the Managing Partner of Cathay Health. Formerly, Eric held the role of Venture Partner with Seventure Partners, a Paris-based venture capital firm, from 2014 to 2021. During this time, he sat on the Board of directors of 13 biotechnology companies as a representative for Seventure and of Sensorion SA as an independent director.

Between 2011 and 2014 Eric was CEO of Delenex Therapeutics, a Zurich-based biotechnology company discovering and developing antibodies for topical application to the skin. From 2005 to 2011 he led Roche’s global function of External Research and Technologies. In this role, he had a dual mandate of BD&L (finding partners, negotiating contracts, managing alliances), leading to more than 200 partnerships being signed; and strategic advisory (R&D scenarios for a 20-year horizon and actionable recommendations). Eric is a scientist by training, with contributions in the field of protein structure determination by X-ray crystallography. He was trained as an engineer and physicist at Ecole Centrale de Paris, holds a Ph.D. in Biophysics from Paris XI University, a post-graduate diploma in biomedicine from IFSBM (Institut Gustave-Roussy), and an MBA (honors) from INSEAD.